AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.
Location: Spain, Catalonia, Barcelona
Member count: 11-50
Total raised: $12.490523M
Founded date: 2014
Investors 2
Date | Name | Website |
- | Ysios Capi... | ysioscapit... |
05.08.2021 | Caixa Capi... | caixacapit... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
11.01.2016 | Series A | $12.490523... | - | caixacapit... |
Mentions in press and media 17
Date | Title | Description | Source |
16.09.2021 | El CDTI invierte junto a Caixa Innvierte Start e Ysios BioFu... | 16/09/2021 Nota de prensa EL CDTI INVIERTE JUNTO A CAIXA INNVIERTE START E YSIOS BIOFUND II INNVIE... | webcapital... |
11.03.2021 | Prometheus upsizes IPO by 33% ahead of pricing; Humanige... | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmar... | endpts.com... |
11.03.2021 | FDA delays Kadmon’s priority review as apparent clam... | Kadmon Holdings just lost their priority review. The immunology biotech announced Wednes... | endpts.com... |
11.03.2021 | Ani Pharma picks up generic player for a cool $210M, tur... | The FDA is continuing its review of cancer drugs that have won accelerated approvals with three days... | endpts.com... |
11.03.2021 | Covid-19 roundup: Pfizer/BioNTech release real-world ev... | With their Covid-19 vaccine having been authorized for roughly three months, Pfizer and BioNT... | endpts.com... |
11.03.2021 | In race for in vivo sickle cell cure, Intellia unveils ... | Vertex and CRISPR Therapeutics have shown they can use the gene editing tool to cure, for at le... | endpts.com... |
11.03.2021 | Gilead partner touts an early snapshot of its HIV vaccin... | More than 2 years after allying itself with HIV giant Gilead on a combo approach to a possi... | endpts.com... |
11.03.2021 | Covid-19 manufacturing roundup: Biden doubles down on v... | With headlines around the globe focused on various hitches in the global supply chain for Cov... | endpts.com... |
11.03.2021 | Ani Pharma picks up generic player for a cool $210M, tur... | Contract manufacturing work has grown at a rapid clip the past year given demand caused in pa... | endpts.com... |
11.03.2021 | Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker... | In nearly nine years helming J&J, CEO Alex Gorsky has watched his drugmaker morph into the ... | endpts.com... |
Show more